Evidence map›Paper›PMID 42046023›Full record

ArticleBMC medical imaging2026

Amyloid-beta statuses prediction with free water MR imaging features in Alzheimer's disease using machine learning models.

Rongshen Zhou, Xuan Sun, Siyu Chen, Shilong Zhao, Cui Zhao, Junda Qu, Weiyi Zeng, Chunlin Li, Xu Zhang, Zihan Li and 5 more

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rongshen Zhou *School of Biomedical Engineering, Capital Medical University, Beijing, China.
Xuan Sun *Department of Neurology, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Siyu ChenDepartment of Neurology, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Shilong ZhaoSchool of Biomedical Engineering, Capital Medical University, Beijing, China.
Cui ZhaoCognitive Science and Allied Health School, Beijing Language and Culture University, Beijing, China.
Junda QuDepartment of Radiology & Precision and Intelligence Medical Imaging Lab, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Weiyi ZengPopulation Health Sciences, German Centre for Neurodegenerative Diseases, Bonn, Germany.
Chunlin LiSchool of Biomedical Engineering, Capital Medical University, Beijing, China.
Xu ZhangSchool of Biomedical Engineering, Capital Medical University, Beijing, China.
Zihan LiMedical School of Chinese PLA, Beijing, China.
Yiqing WangMedical School of Chinese PLA, Beijing, China.
Ting ZhangInstitute of Geriatrics, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Xian XuDepartment of Radiology, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China. xuxian_301@163.com.
Jianjun JiaInstitute of Geriatrics, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China. jiajianjun301@126.com.
Ying LiangSchool of Biomedical Engineering, Capital Medical University, Beijing, China. yingliang@ccmu.edu.cn.

Funding

National Key Research and Development Program of China 2023YFC3605403National Key Research and Development Program of China 2023YFF1203502the National Natural Science Foundation of China 31600933the National Natural Science Foundation of China 62171300the National Natural Science Foundation of China 62401072
6 · The paper itself

Abstract

purposeThis study aimed to identify the effectiveness of free water MRI (FW-MRI) features for predicting amyloid-beta (Aβ) statuses in Alzheimer’s disease (AD) by constructing diagnostic models using machine learning analysis.

methodsThis study retrospectively included 96 patients of mild cognitive impairment (MCI) and AD (69 Aβ-positive and 27 Aβ-negative). Clinical characteristics, FW-corrected and standard diffusion indices, and structural MRI indices were collected. Three supervised machine learning algorithms, including random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGB), were adopted to construct a diagnostic model for distinguishing Aβ deposition in AD. SHapley Additive exPlanation (SHAP) value was used as an interpretable algorithm to identify influential characteristics based on the best-performing model.

resultsIn the single-modality model, FW-DTI achieved better classification performance than conventional DTI, which obtained accuracies all above 80% among three machine learning approaches on the internal dataset (RF = 0.800, SVM = 0.867, XGB = 0.800). In the multi-modality model, the XGB model integrated FW-DTI, voxel-based morphometry, and clinical features outperformed the RF and SVM models, achieving an accuracy of 86.7% and an area under the curves (AUC) value 93.2% in the training cohort, and an accuracy of 77.8% and AUC value of 83.1% in the external testing cohort. The model demonstrated high sensitivity but relatively low specificity, indicating a tendency toward positive predictions. Furthermore, FW-DTI indices were shown to have the highest predictive value for Aβ deposition.

conclusionIntegrating FW-DTI with structural and clinical features effectively differentiated Aβ positivity in AD, with FW-DTI indices contributing the highest predictive risks, demonstrating the potential of FW-DTI in AD diagnosis.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCognitive DysfunctionMachine LearningMagnetic Resonance ImagingAgedBoosting Machine Learning AlgorithmsClassification AlgorithmsDiffusion Tensor ImagingFemaleHumansMalePrediction AlgorithmsPredictive Learning ModelsRandom ForestRetrospective StudiesAmyloid beta-PeptidesWaterAlzheimer’s diseaseAmyloid-betaClassification modelFree water diffusion tensor imagingMachine learning

Identifiers

PMID42046023
PMCPMC13130614

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.